Cell cycle regulation of the endogenous wild type Bloom's syndrome DNA helicase

被引:102
作者
Dutertre, S
Ababou, M
Onclercq, R
Delic, J
Chatton, B
Jaulin, C
Amor-Guéret, M
机构
[1] Inst Gustave Roussy, CNRS, UMR 1598, F-94805 Villejuif, France
[2] Inst Curie, Lab Radiopathol, CEA, Lab Rech Correspondant,DSV,DRR, F-75005 Paris, France
[3] ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, CU De Strasbour, France
关键词
Bloom's syndrome; RecQ 3 '-5 ' DNA helicase; cell cycle; post-translational modifications; cancer predisposition;
D O I
10.1038/sj.onc.1203595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bloom's syndrome (BS) is a rare human autosomal recessive disorder characterized by an increased risk to develop cancer of all types, BS cells are characterized by a generalized genetic instability including a high level of sister chromatid exchanges, BS arises through mutations in both alleles of the BLM gene which encodes a 3'-5' DNA helicase identified as a member of the RecQ family. We developed polyclonal antibodies specific for the NH2- and COOH-terminal region of BLM, Using these antibodies, we analysed BLM expression during the cell cycle and showed that the BLM protein accumulates to high levels in S phase, persists in G2/M and sharply declines in G1, strongly suggestive of degradation during mitosis, The BLM protein is subject to post-translational modifications in mitosis, as revealed by slow migrating forms of BLM found in both demecolcine-treated cells and in mitotic cells isolated from non-treated asynchronous populations. Phosphatase treatment indicated that phosphorylation events were solely responsible for the appearance of the retarded moieties, a possible signal for subsequent degradation. Together, these results are consistent with a role of BLM in a replicative (S phase) and/or post-replicative (G2 phase) process.
引用
收藏
页码:2731 / 2738
页数:8
相关论文
共 42 条
[1]   beta-catenin is a target for the ubiquitin-proteasome pathway [J].
Aberle, H ;
Bauer, A ;
Stappert, J ;
Kispert, A ;
Kemler, R .
EMBO JOURNAL, 1997, 16 (13) :3797-3804
[2]   Point mutations causing Bloom's syndrome abolish ATPase and DNA helicase activities of the BLM protein [J].
Bahr, A ;
De Graeve, F ;
Kedinger, C ;
Chatton, B .
ONCOGENE, 1998, 17 (20) :2565-2571
[3]  
Chakraverty RK, 1999, BIOESSAYS, V21, P286
[4]   Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene [J].
Chester, N ;
Kuo, F ;
Kozak, C ;
O'Hara, CD ;
Leder, P .
GENES & DEVELOPMENT, 1998, 12 (21) :3382-3393
[5]   Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation [J].
Clurman, BE ;
Sheaff, RJ ;
Thress, K ;
Groudine, M ;
Roberts, JM .
GENES & DEVELOPMENT, 1996, 10 (16) :1979-1990
[6]  
COUX O, 1996, ANNU REV BIOCHEM, V65, P80
[7]   THE BLOOMS-SYNDROME GENE-PRODUCT IS HOMOLOGOUS TO RECQ HELICASES [J].
ELLIS, NA ;
GRODEN, J ;
YE, TZ ;
STRAUGHEN, J ;
LENNON, DJ ;
CIOCCI, S ;
PROYTCHEVA, M ;
GERMAN, J .
CELL, 1995, 83 (04) :655-666
[8]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[9]  
Frei C, 2000, GENE DEV, V14, P81
[10]   THE YEAST TYPE-I TOPOISOMERASE TOP3 INTERACTS WITH SGS1, A DNA HELICASE HOMOLOG - A POTENTIAL EUKARYOTIC REVERSE GYRASE [J].
GANGLOFF, S ;
MCDONALD, JP ;
BENDIXEN, C ;
ARTHUR, L ;
ROTHSTEIN, R .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :8391-8398